Cargando…
Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway
Danshen (Salvia miltiorrhiza Bunge) is widely used in traditional Chinese medicine. In our study, the in vivo protective effect of danshen in prostate cancer patients was validated through data from the National Health Insurance Research Database in Taiwan. In vitro, we discovered that dihydroisotan...
Autores principales: | Wu, Ching-Yuan, Yang, Yao-Hsu, Lin, Yin-Yin, Kuan, Feng-Che, Lin, Yu-Shin, Lin, Wei-Yu, Tsai, Ming-Yen, Yang, Jia-Jing, Cheng, Yu-Ching, Shu, Li-Hsin, Lu, Ming-Chu, Chen, Yun-Ju, Lee, Kuan-Der, Kang, Hong-Yo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522253/ https://www.ncbi.nlm.nih.gov/pubmed/28157698 http://dx.doi.org/10.18632/oncotarget.14958 |
Ejemplares similares
-
Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells
por: Lin, Yu-Shih, et al.
Publicado: (2019) -
Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway
por: Lee, I-Yun, et al.
Publicado: (2018) -
Induction of ferroptosis and apoptosis in endometrial cancer cells by dihydroisotanshinone I
por: Wu, Ching-Yuan, et al.
Publicado: (2023) -
Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells
por: Wu, Ching-Yuan, et al.
Publicado: (2017) -
Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas
por: Hsu, Cheng-Ming, et al.
Publicado: (2021)